Ingredient
Pueraria Mirifica Root Extract
Pueraria Mirifica Root Extract is flagged for pregnancy, breastfeeding, trying to conceive, PCOS, postpartum and general use. The concern behind the strongest flag is hormone disruptor and fetal development.
- White Kwao Krua
- Kwao Krua Kao
- Thai Kudzu
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Pueraria Mirifica Root Extract and pregnancy
Not Recommended
- Hormone disruptor
- Fetal development
Pueraria Mirifica contains potent phytoestrogens including miroestrol and deoxymiroestrol, which have significant estrogenic activity. The root extract is traditionally used specifically for its hormonal effects, containing compounds that can mimic estrogen in the body. During pregnancy, hormone balance is critical for fetal development, and introducing external estrogenic compounds poses theoretical risks. According to ACOG, substances with strong hormonal activity should be avoided during pregnancy due to potential effects on fetal development, particularly the reproductive system. While specific studies on topical Pueraria Mirifica during pregnancy are lacking, the potency of its phytoestrogens raises significant concerns about potential hormonal disruption. Most obstetricians and dermatologists recommend avoiding all products with strong phytoestrogen content during pregnancy, including Pueraria Mirifica. The precautionary principle applies here: given the known hormonal activity and the importance of stable hormone levels during pregnancy, it's advisable to avoid this ingredient entirely until after delivery.
Pueraria Mirifica Root Extract and breastfeeding
Not Recommended
- Hormone disruptor
- Infant exposure
Pueraria Mirifica root extract contains miroestrol and deoxymiroestrol, phytoestrogens with potent estrogenic activity. These compounds can potentially be absorbed through the skin and enter the bloodstream. The concern during breastfeeding is that phytoestrogens can pass into breast milk and expose the infant to hormone-like compounds during a critical developmental period. While specific data on Pueraria Mirifica in breast milk is lacking, studies show that phytoestrogens from diet do appear in breast milk. The AAD notes that substances with hormonal activity should be approached with caution while breastfeeding, as infant hormone exposure could theoretically affect development. Given the potent estrogenic nature of this plant extract and the lack of safety data for breastfed infants, most lactation consultants and dermatologists recommend avoiding Pueraria Mirifica while breastfeeding. Safer alternatives without hormonal activity are widely available for anti-aging and skin benefits.
Pueraria Mirifica Root Extract and postpartum
Caution Advised
- Hormone disruptor
For postpartum women who are not breastfeeding, Pueraria Mirifica presents less risk than during pregnancy or breastfeeding, but the hormonal activity still warrants caution. The body is still rebalancing hormones after pregnancy, and introducing phytoestrogens may interfere with this natural process. If considering products with this ingredient, wait until hormonal cycles have normalized (typically several months postpartum). Women with a history of hormone-sensitive conditions, including postpartum thyroid issues or irregular cycles, should consult their healthcare provider before using products containing Pueraria Mirifica.
Pueraria Mirifica Root Extract and trying to conceive
Not Recommended
- Hormone disruptor
- Fertility effects
Pueraria Mirifica's potent phytoestrogens can affect hormone balance, which is critical when trying to conceive. Normal ovulation and fertility depend on precise hormonal cycling, and introducing external estrogenic compounds could theoretically interfere with this process. While specific fertility studies on topical Pueraria Mirifica are lacking, reproductive endocrinologists generally recommend avoiding strong phytoestrogen sources when trying to conceive. The principle is similar to pregnancy: maintain optimal hormonal environment without external disruption. Women undergoing fertility treatments should especially avoid this ingredient, as it could potentially interfere with carefully timed hormonal protocols.
Pueraria Mirifica Root Extract and PCOS
Not Recommended
- Interferes with hormones
- Affects estrogen
Pueraria Mirifica contains potent phytoestrogens that can significantly affect hormone balance. For individuals with PCOS, who already have hormonal imbalances involving elevated androgens and often disrupted estrogen-progesterone ratios, introducing strong phytoestrogens is problematic. PCOS management focuses on achieving hormonal balance through diet, lifestyle, and sometimes medication. The estrogenic compounds in Pueraria Mirifica could potentially interfere with this balance or interact with medications like metformin or hormonal contraceptives used to manage PCOS. Studies on oral Pueraria Mirifica supplements have shown measurable effects on hormone levels, suggesting the compounds are bioavailable. Endocrinologists and dermatologists generally advise individuals with PCOS to avoid potent phytoestrogen sources like Pueraria Mirifica. The risk of disrupting carefully managed hormone balance outweighs any potential cosmetic benefits, especially when safer alternatives exist for addressing PCOS-related skin concerns.
Pueraria Mirifica Root Extract and general use
Caution Advised
- Endocrine disruptor
Pueraria Mirifica root extract is marketed in skincare for its anti-aging benefits, which are attributed to its phytoestrogen content. These plant compounds can potentially improve skin elasticity and hydration by mimicking estrogen's effects on skin, though topical efficacy studies are limited. The concern for the general population is that regular topical application of potent phytoestrogens may have subtle hormonal effects, particularly with long-term use. Individuals with hormone-sensitive conditions (breast cancer history, endometriosis, uterine fibroids, thyroid disorders) should avoid this ingredient. Even healthy individuals should consider whether the theoretical benefits outweigh the uncertainty around systemic absorption and hormonal effects. While not prohibited by regulatory bodies, the lack of comprehensive safety data on topical Pueraria Mirifica and its known strong estrogenic activity suggest a cautious approach. Many dermatologists recommend choosing skincare ingredients with better-established safety profiles, especially given the availability of effective alternatives without hormonal concerns.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Pueraria Mirifica Root Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store